<--- Back to Details
First PageDocument Content
Biology / Peptide hormones / Recombinant proteins / Medicine / Insulin analog / Insulin therapy / Insulin aspart / Insulin pump / Novo Nordisk / Diabetes / Endocrine system / Eli Lilly and Company
Date: 2014-05-05 10:56:54
Biology
Peptide hormones
Recombinant proteins
Medicine
Insulin analog
Insulin therapy
Insulin aspart
Insulin pump
Novo Nordisk
Diabetes
Endocrine system
Eli Lilly and Company

PREFERRED STEP THERAPY POLICY Insulin (Rapid-Acting) Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Apidra® (insulin glulisine [rDNA origin] injection – Sanofi Aventi

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 95,91 KB